ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01686152
Recruitment Status : Completed
First Posted : September 17, 2012
Last Update Posted : December 6, 2013
Sponsor:
Information provided by (Responsible Party):
Teva Pharmaceuticals USA

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2013
  Actual Study Completion Date : August 2013